MARK ANDREW WALSHAUSER (M.D.) – Hematology & Oncology Physician, NPI 1306020664

MARK ANDREW WALSHAUSER (M.D.) is a healthcare provider. based in Swansea, Illinois. specializing in HEMATOLOGY/ONCOLOGY. They hold the professional credentials M.D.. They hold a License No. 2010024540 (MO). The NPI Number for MARK ANDREW WALSHAUSER (M.D.) is 1306020664

Main info

Male
20 Years Of Experience
Accepts Medicare Assignment
Name
MARK ANDREW WALSHAUSER (M.D.)
NPI
1306020664
Phone
(618) 416-7970
Address
13 WOLF CREEK DR STE 1
Enumeration Date
21 December 2007
Last Update Date
12 December 2023

Doctor Profile

Medical School Name
OTHER
Secondary Phone
6184167970
Graduation Year
2006 (20 years ago)
PAC ID
0345365227
Group Practice PAC ID
5991619116
Professional Enrollment ID
I20140711000552
Address ID
IL622691887OX321XXPARK301
Telehealth
Yes
Data current as of
20 May 2026

Profile Insights

NPPES metrics only — not quality of care.

Methodology
Experience74
Completeness75
Years active:18State licenses:2Digital endpointsOther names

727 HEMATOLOGY/ONCOLOGY in IL

Loading map...

Provider Addresses for MARK ANDREW WALSHAUSER (M.D.)

  • 1, Wolf Creek Drive, Swansea, Saint Clair County, Illinois, 62226, United States

    SWANSEA, IL 622262367

    Phone: (618) 416-7970

    Type: Mailing

  • 321 REGENCY PARK STE 100

    O FALLON, IL 622691887

    Phone: (618) 416-7970

    Fax: (618) 416-7971

    Type: Location

  • Broadway Plaza Suite 1

    Sparta, IL 622861800

    Phone: (618) 416-7970

    Fax: (618) 416-7971

    Type: Location

  • 12860 Troxler Ave Ste 135

    Highland, IL 622492898

    Phone: (618) 416-7970

    Fax: (618) 416-7971

    Type: Location

  • PO BOX 25228

    DECATUR, IL 625255228

    Phone: (217) 329-3232

    Fax: (217) 233-1670

    Type: Mailing

NPPES updates history

No NPPES updates recorded for this provider.

Prescription Activity

Loading prescription activity...

Open Payments (CMS)

CMS reports 189 Open Payments records for all available years, with a total value of $11,578.

Total Amount is formed as General ($11,578) + Research ($0) + Ownership ($0) = $11,578.

Last reported payment date: 2024-12-16 • Largest payer in this snapshot: Regeneron Pharmaceuticals, Inc. ($3,833).

Total Amount

$11,578

General + Research + Ownership

Payments

189

Total payment records

General Amount

$11,578

General payments

Research Amount

$0

Research funding

Ownership Amount

$0

Ownership interests

Ownership Count

0

Ownership records

Last Payment Date

2024-12-16

Latest reported date

Top Companies

Largest payers in this snapshot

View all Open Payments →|Open Payments Risk Radar →

Medicare Enrollment & Revalidation

Source: CMS public data · Not endorsed by CMS ·

Educational use only—not medical, billing, or legal advice.

PECOS enrollment status

Participating (accepts Medicare assignment)

Enrollment effective: 2014-07-11

PECOS data refreshed: 2026-05-27

Medicare revalidation (CMS due date list)

Past revalidation due date

Earliest CMS due date was 2023-07-31 (1043 days ago).

Enrollment records

1

Earliest due date

2023-07-31

CMS data updated

2026-06-01

Revalidation progress

  1. Medicare enrolled
  2. On CMS revalidation list
  3. Due date assigned
  4. Revalidate in PECOS

CMS enrollment records

Enrollment IDTypeSpecialtyStateDue date
I20140711000552IHematology/OncologyIL2023-07-31

What to do next

  • Verify current status on the CMS Revalidation Lookup Tool immediately.
  • Complete revalidation in PECOS or contact your Medicare Administrative Contractor (MAC).
  • Overdue revalidation can lead to deactivation of Medicare billing privileges.

Verify on CMS Revalidation Lookup Tool

Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS

Medicare Utilization (FFS)

Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·

Educational use only—not medical, billing, or legal advice.

Top Medicare procedures (2023) · refreshed 2026-05-27

HCPCSDescriptionServicesBeneficiariesMedicare allowed
J1439Injection, ferric carboxymaltose, 1 mg43,50028$0
Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml14,30074$0
J1100Injection, dexamethasone sodium phosphate, 1 mg2,68737$0
J2469Injection, palonosetron hcl, 25 mcg1,52022$0
96375Injection of additional new drug or substance into vein1,11854$0
View full utilization report →

Insurance plans in this area (ZIP 62226)

Loading plans...

Provider's Procedures

MARK ANDREW WALSHAUSER (M.D.) performs procedures in HEMATOLOGY/ONCOLOGY. See the list of HCPCS codes below.
SpecialtyPractice State
HCPCS Code
Description
Service Count
Beneficiary Count
HEMATOLOGY/ONCOLOGYIL96375Injection of different drug or substance into a vein for therapy, diagnosis, or prevention21524
HEMATOLOGY/ONCOLOGYIL96415Infusion of chemotherapy into a vein8314

Group practice members

Group practice members are other physicians who share the same Group Practice PAC ID with this doctor. When doctors form a group practice and register in PECOS as a single entity, they receive a shared identification number. This table lists all providers in the same group practice.
PAC ID: 5991619116View full group profile
NameSpecialtyState
Nurse PractitionerIL
Nurse PractitionerIL
Nurse PractitionerIL
Nurse PractitionerIL
Nurse PractitionerIL
Nurse PractitionerIL
H E M A T O L O G Y/ O N C O L O G YIL
H E M A T O L O G Y/ O N C O L O G YIL
Hematology/Oncology, Internal MedicineIL
H E M A T O L O G Y/ O N C O L O G YIL

Reviews

All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.

No reviews yet. Be the first to share your experience — your opinion helps families compare providers.

Frequently asked questions

How do payers reference MARK ANDREW WALSHAUSER (M.D.)?
For MARK ANDREW WALSHAUSER (M.D.), use NPI 1306020664 as the unique 10-digit identifier.
Would MARK ANDREW WALSHAUSER (M.D.) appear as active to a payer?
You can treat MARK ANDREW WALSHAUSER (M.D.) as active for directory purposes; confirm clinical privileges separately.
What expertise is attributed to MARK ANDREW WALSHAUSER (M.D.)?
MARK ANDREW WALSHAUSER (M.D.)'s specialty line reads Hematology & Oncology Physician. Clinical services aligned with this taxonomy classification.
Is MARK ANDREW WALSHAUSER (M.D.) associated with Swansea?
Public fields place MARK ANDREW WALSHAUSER (M.D.) around Swansea, Illinois. Always confirm the exact site before visiting.
When was this NPI issued?
Enumeration for MARK ANDREW WALSHAUSER (M.D.) is noted as December 21, 2007 where the registry provides it.

Similar Providers

DR. MORTON A LEVY (MD)

Hematology & Oncology Physician
Swansea, Saint Clair County, Illinois, 62226, United States
NPI: 1811999030

DR. KOCHURANI J MALIEKEL (MD)

Hematology & Oncology Physician
3851, North Oakley Avenue, North Center, Roscoe Village, Chicago, Lake View Township, Cook County, Illinois, 60618, United States
NPI: 1699777813

DR. SAMUEL A. BURSTEIN (M.D.)

Hematology & Oncology Physician
North Illinois Lane, Swansea, Saint Clair County, Illinois, 62226, United States
NPI: 1306894233

ILLINOIS ONCOLOGY LTD

Hematology & Oncology Physician
4000, North Illinois Lane, Swansea, Saint Clair County, Illinois, 62226, United States
NPI: 1659568764